GlassScriptPhysician profile
Tara A Geha
NPI 1760516611
$635.27
in general payments reported to CMS, 2019-2025
13 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $141 · 2023: $143 · 2024: $37.34 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $111.93 | 2021-2025 | |
| Smith+Nephew, INC. | $84.35 | 2021-2022 | |
| Integra Lifesciences Corporation | $68.80 | 2021-2023 | Tenoglide |
| Janssen Pharmaceuticals, INC | $66.06 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $64.33 | 2023 | Andexxa |
| Vertex Pharmaceuticals Incorporated | $51.74 | 2025 | |
| Tela Bio, INC. | $49.95 | 2021-2022 | |
| Axogen | $35.51 | 2025 | Axoguard Ha+ Nerve Protector |
| Kci USA, INC. | $30.02 | 2021-2023 | Snap, Activ.A.C. |
| Heron Therapeutics, INC. | $25.00 | 2023 | Zynrelef |
| Merz North America, INC. | $18.88 | 2022 | |
| Solventum Corporation | $14.56 | 2024 | Activ.A.C. |
| Medtronic, INC. | $14.14 | 2025 | Transorb |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Geha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.